Two approaches to tackling COVID-19 in patients with blood cancer

Nat Cancer. 2023 Jan;4(1):5-6. doi: 10.1038/s43018-022-00505-8.
No abstract available

Publication types

  • Comment

MeSH terms

  • COVID-19*
  • Hematologic Neoplasms* / complications
  • Hematologic Neoplasms* / epidemiology
  • Hematologic Neoplasms* / therapy
  • Humans
  • Neoplasms* / epidemiology
  • Neoplasms* / therapy
  • Patients